Oral Conventional Synthetic Disease-Modifying Antirheumatic Drugs with Antineoplastic Potential: a Review

There is an increasing trend of malignancy worldwide. Disease-modifying antirheumatic drugs (DMARDs) are the cornerstones for the treatment of immune-mediated inflammatory diseases (IMIDs), but risk of malignancy is a major concern for patients receiving DMARDs. In addition, many IMIDs already carry...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Cho-Hsun, Huang, Yi-Wei, Tsai, Tsen-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021342/
https://www.ncbi.nlm.nih.gov/pubmed/35381976
http://dx.doi.org/10.1007/s13555-022-00713-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021342/
https://www.ncbi.nlm.nih.gov/pubmed/35381976
http://dx.doi.org/10.1007/s13555-022-00713-1

Ejemplares similares